Figure 2.

Point estimate and 95% CI response to ezetimibe 10 mg/d in sitosterol in various subgroups of population, defined by baseline characteristics. For baseline sitosterol subgroup, median sitosterol concentration used was based on all randomized subjects; 18 subjects (6 placebo and 12 ezetimibe) had plasma sitosterol levels at or below median at baseline, and 18 subjects (1 placebo and 17 ezetimibe) had baseline sitosterol levels above median. BSBR indicates bile salt-binding resin.